Select Page

According to a new report Global Pain Management Devices Market, published by KBV research, The Global Pain Management Devices Market size is expected to reach $6.3 billion by 2026, rising at a market growth of 8.5% CAGR during the forecast period.

Neuromodulation & neurostimulation devices are currently leading the global market, and this trend is projected to continue over the forecast period, due to the rise in demand for neuromodulation & neurostimulation devices, the cost efficiency provided by these devices, the rise in the target population.

Currently, neuropathic pain accounts for the majority of market share due to rising target population numbers, technological advances in pain management devices, rising demand for pain management devices for neuropathic pain management. The Cancer Pain market is anticipated to grow with highest CAGR of 8.8% during (2020 – 2026).
The North America market dominated the Global Pain Management Devices Market by Region in 2019. Asia-Pacific provides lucrative opportunities for key players operating on the market for pain management devices due to increased knowledge of implantable pain management devices and increased acceptance of pain management devices products. Additionally, The Europe market is expected to witness a CAGR of 8.1% during (2020 – 2026).

Structural Insights: https://www.kbvresearch.com/pain-management-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)

Global Pain Management Devices Market Segmentation

By Product
• Neuromodulation & Neurostimulation Devices
• Analgesic Infusion Pumps and
• Ablation Devices

By Application
• Neuropathic Pain
• Musculoskeletal Pain
• Cancer Pain
• Facial & Migraine Pain and
• Other Applications

By Geography

North America
• US
• Canada
• Mexico
• Rest of North America

Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled
• Abbott Laboratories
• Braun Melsungen AG
• Baxter International, Inc.
• Pfizer, Inc.
• Boston Scientific Corporation
• Johnson and Johnson
• Medtronic PLC
• Kimberly-Clark Corporation
• Stryker Corporation
• Colfax Corporation (DJO Global, Inc.)